Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. UPXI
UPXI logo

UPXI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Upexi, Inc (UPXI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.380
1 Day change
2.99%
52 Week Range
18.900
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Upexi, Inc (UPXI) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows strong revenue growth and an improving gross margin, the significant net income loss and negative EPS are concerning. Additionally, the technical indicators and trading signals do not strongly support a buy decision, and there are no significant positive news or catalysts to drive immediate growth.

Technical Analysis

The MACD histogram is positive at 0.0388, indicating slight bullish momentum, but it is contracting. RSI is neutral at 64.774, and moving averages are converging, showing no clear trend. The stock is trading near its R1 resistance level of 1.492, with limited upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate bullish sentiment, but the overall volume and open interest are not significant enough to confirm strong market conviction.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
7

Positive Catalysts

  • Revenue increased by 101.02% YoY, and gross margin improved to 81.44%, showing operational efficiency.

Neutral/Negative Catalysts

  • There is no recent news or significant trading activity by insiders, hedge funds, or influential figures.

Financial Performance

In Q2 2026, Upexi's revenue grew by 101.02% YoY to 8,052,040, and gross margin improved by 19.29% YoY to 81.44%. However, net income remains deeply negative at -178,924,930, despite a 13,649.60% YoY improvement. EPS also remains negative at -2.94, up 137.10% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Cantor Fitzgerald lowered the price target from $6 to $2 but maintained an Overweight rating. This reflects reduced expectations but continued belief in the company's potential.

Wall Street analysts forecast UPXI stock price to rise
1 Analyst Rating
Wall Street analysts forecast UPXI stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.340
sliders
Low
6
Averages
6
High
6
Current: 1.340
sliders
Low
6
Averages
6
High
6
Cantor Fitzgerald
Brett Knoblauch
Overweight
downgrade
$6 -> $2
AI Analysis
2026-02-11
Reason
Cantor Fitzgerald
Brett Knoblauch
Price Target
$6 -> $2
AI Analysis
2026-02-11
downgrade
Overweight
Reason
Cantor Fitzgerald analyst Brett Knoblauch lowered the firm's price target on Upexi to $2 from $6 and keeps an Overweight rating on the shares following the Q2 results. The firm continues to believe the Solana ecosystem is one of the most "vibrant" ecosystems across crypto, and while recent price performance paints a negative light on Solana, the core thesis that Solana can be the internet of capital markets remains true, the analyst tells investors in a research note.
Cantor Fitzgerald
Overweight -> NULL
downgrade
$16 -> $6
2025-11-14
Reason
Cantor Fitzgerald
Price Target
$16 -> $6
2025-11-14
downgrade
Overweight -> NULL
Reason
Cantor Fitzgerald lowered the firm's price target on Upexi to $6 from $16 and keeps an Overweight rating on the shares. With a large SOL treasury, discounted valuation, and new share repurchase authorization, the setup offers an appealing risk/reward profile, the analyst tells investors in a research note. The firm has removed the value applied to its treasury operations from its model.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for UPXI
Unlock Now

People Also Watch